A toolbox for enzymatic modification of nucleic acids with photosensitizers for photodynamic therapy

Germain Niogret, Camille Chériaux, Frédéric Bonhomme, Fabienne Levi-Acobas, Carlotta Figliola, Gilles Ulrich, Gilles Gasser and Marcel Hollenstein

RSC Chem. Biol., 2024, 5, 841
DOI: 10.1039/D4CB00103F

The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2

Ruiqi Huang, Gabrielle Warner Jenkins, Yunjeong Kim, Robyn L. Stanfield, Amrinder Singh, Maria Martinez-Yamout, Gerard J. Kroon, Jonathan L. Torres, Abigail M. Jackson, Abigail Kelley, Namir Shaabani, Baisen Zeng, Michael Bacica, Wen Chen, Christopher Warner, Jasmina Radoicic, Joongho Joh, Krishani Dinali Perera, Huldah Sang, Tae Kim, Jianxiu Yao, Fangzhu Zhao, Devin Sok, Dennis R. Burton, Jeff Allen, William Harriman, Waithaka Mwangi, Donghoon Chung, John R. Teijaro, Andrew B. Ward, H. Jane Dyson, Peter E. Wright, Ian A. Wilson, Kyeong-Ok Chang, Duncan McGregor and Vaughn V. Smider

Proc. Natl. Acad. Sci. U.S.A., 2023, 120
DOI: 10.1073/pnas.2303455120

Replication-competent influenza virus with a protein-responsive multiplication ability

Shinzi Ogasawara

New Biotechnology, 2023, 77, 100
DOI: 10.1016/j.nbt.2023.08.001

Strategies to boost antibody selectivity in oncology

Vincent Blay and Atanasio Pandiella

Trends in Pharmacological Sciences, 2024, 45, 1135
DOI: 10.1016/j.tips.2024.10.005

Principles and Design of Molecular Tools for Sensing and Perturbing Cell Surface Receptor Activity

Jennifer Sescil, Steven M. Havens and Wenjing Wang

Chem. Rev., 2025, 125, 2665
DOI: 10.1021/acs.chemrev.4c00582

Albumin incorporation into recognising layer of HER2-specific magnetic nanoparticles as a tool for optimal targeting of the acidic tumor microenvironment

Olga A. Kolesnikova, Elena N. Komedchikova, Svetlana D. Zvereva, Anastasiia S. Obozina, Olha V. Dorozh, Iurii Afanasev, Petr I. Nikitin, Elizaveta N. Mochalova, Maxim P. Nikitin and Victoria O. Shipunova

Heliyon, 2024, 10, e34211
DOI: 10.1016/j.heliyon.2024.e34211

A novel HER2 targeting nanoagent self-assembled from affibody-epothilone B conjugate for cancer therapy

Xuelin Xia, Xiaoyuan Yang, Wenhui Gao, Wei Huang, Xiaoxia Xia and Deyue Yan

J Nanobiotechnol, 2024, 22
DOI: 10.1186/s12951-024-02754-4

Molecular Imaging of Tumor-Infiltrating Lymphocytes in Living Animals Using a Novel mCD3 Fibronectin Scaffold

Char Wynter, Arutselvan Natarajan, Clyde John, Kaahini Jain and Ramasamy Paulmurugan

Bioconjugate Chem., 2025, 36, 104
DOI: 10.1021/acs.bioconjchem.4c00501

Novel Molecular Classification of Breast Cancer with PET Imaging

Ngô Minh Toàn

Medicina, 2024, 60, 2099
DOI: 10.3390/medicina60122099

Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase

Nina Schmidt, Amit Kumar, Lukas Korf, Adrian Valentin Dinh-Fricke, Frank Abendroth, Akiko Koide, Uwe Linne, Magdalena Rakwalska-Bange, Shohei Koide, Lars-Oliver Essen, Olalla Vázquez and Oliver Hantschel

Nat Commun, 2024, 15
DOI: 10.1038/s41467-024-54901-y

Transformative protein scaffold designs for dual-modality cancer applications: Advances in therapeutic delivery and molecular imaging of tumor microenvironments

Mohammed Alissa, Abdullah Alghamdi, Suad A. Alghamdi, Mohammed A. Alshehri, Ghfren S. Aloraini, Abdullah Albelasi and Mohammed S. Alshammari

International Journal of Biological Macromolecules, 2025, 318, 144881
DOI: 10.1016/j.ijbiomac.2025.144881

Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins

Alexander Chan, Rebecca M. Haley, Mohd Altaf Najar, David Gonzalez-Martinez, Lukasz J. Bugaj, George M. Burslem, Michael J. Mitchell and Andrew Tsourkas

Nat Commun, 2024, 15
DOI: 10.1038/s41467-024-50235-x

Boron Nanoparticle-Enhanced Proton Therapy: Molecular Mechanisms of Tumor Cell Sensitization

Anton L. Popov, Danil D. Kolmanovich, Nikita N. Chukavin, Ivan V. Zelepukin, Gleb V. Tikhonowski, Andrei I. Pastukhov, Anton A. Popov, Alexander E. Shemyakov, Sergey M. Klimentov, Vladimir A. Ryabov, Sergey M. Deyev, Irina N. Zavestovskaya and Andrei V. Kabashin

Molecules, 2024, 29, 3936
DOI: 10.3390/molecules29163936

Non-Immunoglobulin Synthetic Binding Proteins for Oncology

Temitope I. David, Nikolay B. Pestov, Tatyana V. Korneenko and Nikolai A. Barlev

Biochemistry Moscow, 2023, 88, 1232
DOI: 10.1134/S0006297923090043

Engineered Antibodies as Cancer Radiotheranostics

Zhenni Wei, Bingyu Li, Xuejun Wen, Vivianne Jakobsson, Peifei Liu, Xiaoyuan Chen and Jingjing Zhang

Advanced Science, 2024, 11
DOI: 10.1002/advs.202402361

Antibody theranostics in precision medicine

Qianyun Wu, Shaowen Yang, Jianjun Liu, Dawei Jiang and Weijun Wei

Med, 2023, 4, 69
DOI: 10.1016/j.medj.2023.01.001

Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting

Kristina Westerlund, Maryam Oroujeni, Maxime Gestin, Jacob Clinton, Alia Hani Rosly, Hanna Tano, Anzhelika Vorobyeva, Anna Orlova, Amelie Eriksson Karlström and Vladimir Tolmachev

ACS Pharmacol. Transl. Sci., 2024, 7, 1595
DOI: 10.1021/acsptsci.4c00106

Non-immunoglobulin synthetic binding proteins for oncology

T. I David, N. B Pestov, T. V Korneenko and N. A Barlev

Biohimiâ, 2023, 88, 1493
DOI: 10.31857/S032097252309004X

Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression

Anzhelika Vorobyeva, Moeen-ud Din, Alexey Schulga, Elena Konovalova, Ayman Abouzayed, Olga Bragina, Ruonan Li, Torbjörn Gräslund, Sergey M. Deyev and Maryam Oroujeni

EJNMMI radiopharm. chem., 2025, 10
DOI: 10.1186/s41181-025-00347-6

Intracellular Protein Delivery: Approaches, Challenges, and Clinical Applications

Alexander Chan and Andrew Tsourkas

BME Front, 2024, 5
DOI: 10.34133/bmef.0035

Next generation of multispecific antibody engineering

Daniel Keri, Matt Walker, Isha Singh, Kyle Nishikawa and Fernando Garces

Antibody Therapeutics, 2024, 7, 37
DOI: 10.1093/abt/tbad027

Fundamental concepts of protein therapeutics and spacing in oncology: an updated comprehensive review

Bahareh Farasati Far, Maryam Safaei, Fatemeh Mokhtari, Mohammad Sadegh Fallahi and Mohammad Reza Naimi-Jamal

Med Oncol, 2023, 40
DOI: 10.1007/s12032-023-02026-5

Engineering protein prenylation: an emerging tool for selective protein modification

Sneha Venkatachalapathy, Caitlin Lichtenfels, Carston R. Wagner and Mark D. Distefano

Biochemical Society Transactions, 2025, 53, 1129
DOI: 10.1042/BST20253076

Adaptive Encapsulation of 1,ω‐Amino‐Acids within the “Pyrene Box”

Shao‐Ping Zheng, Wei‐Xu Feng, Ji‐Jun Jiang, Dawei Wang, Arie van der Lee and Mihail Barboiu

Israel Journal of Chemistry, 2024, 64
DOI: 10.1002/ijch.202300021

Unlocking the power of affibody conjugated radioactive metallopharmaceuticals for targeted cancer diagnosis and therapy

Dhanashree Murugan, Harashkumar Vasanthakumari Thirumalaiswamy, Vasanth Murugesan, Janarthanan Venkatesan, Unnikrishnan Balachandran, Kalaiarasu Lakshminarayanan, Drishty Satpati, Stefan Nikolić and Loganathan Rangasamy

Pharmacology & Therapeutics, 2025, 272, 108863
DOI: 10.1016/j.pharmthera.2025.108863

Modified Knottins as Potential Inhibitors of HCV NS3 Protease

A.V. Talanova, D.S. Shcherbinin, E.F. Kolesanova and A.V. Veselovsky

BMCRM, 2024, 7, e00235
DOI: 10.18097/BMCRM00235

In silico design of ankyrin repeat proteins that bind to the insulin-like growth factor type 1 receptor

José Daniel Mahecha-Ortíz, Sergio Enríquez-Flores, Ignacio De la Mora De la Mora, Luis A. Flores-López, Pedro Gutierrez-Castrellón, Gabriel López-Velázquez, Ruth Sánchez-Mora and Itzhel García-Torres

Journal of Molecular Graphics and Modelling, 2025, 139, 109055
DOI: 10.1016/j.jmgm.2025.109055

High‐throughput screening and biological display technology: Applications in molecular imaging

Renli Luo, Hongguang Liu and Zhen Cheng

iRADIOLOGY, 2023, 1, 18
DOI: 10.1002/ird3.11

Chemically Engineered Affinity Protein Drugs for Covalent Targeted Cancer Therapy

Xuelin Xia, Wenhui Gao, Xiaoyuan Yang, Wei Huang, Xiao-Xia Xia and Deyue Yan

J. Am. Chem. Soc., 2025, 147, 19687
DOI: 10.1021/jacs.5c02212

A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy

Federico Riccardi, Michele Dal Bo, Paolo Macor and Giuseppe Toffoli

Front. Pharmacol., 2023, 14
DOI: 10.3389/fphar.2023.1274088

Phage display technology and its impact in the discovery of novel protein-based drugs

Catherine J. Hutchings and Aaron K. Sato

Expert Opinion on Drug Discovery, 2024, 19, 887
DOI: 10.1080/17460441.2024.2367023

Potential of Theranostics in Visualisation of the Tumour Microenvironment and Elimination of Its Immunosuppressive Components

O. E. Molchanov, D. N. Maystrenko and A. A. Stanzhevskiy

Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya, 2022, 12, 425
DOI: 10.30895/1991-2919-2022-12-4-425-443

cDNA Display Selection of Interacting Peptide Ligands of the Guanylate Cyclase C Receptor

Eri Ochiai, Yuki Takahashi, Shota Inokuchi, Akie Sumiya and Makoto Hasegawa

Journal of Peptide Science, 2025, 31
DOI: 10.1002/psc.3663

Complete preclinical evaluation of the novel antibody mimetic Nanofitin-IRDye800CW for diverse non-invasive diagnostic applications in the management of HER-2 positive tumors

Margherita Iaboni, Federico Crivellin, Francesca Arena, Francesca La Cava, Alessia Cordaro, Francesco Stummo, Daniele Faletto, Simon Huet, Leo Candela, Jessy Pedrault, Eugenia R. Zanella, Andrea Bertotti, Francesco Blasi, Alessandro Maiocchi, Luisa Poggi and Erika Reitano

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-93696-w

Design of Hepatitis C Protease Inhibitors Based on Knottin Fold

Anastasia Talanova, Dmitrii Shcherbinin, Ekaterina Kolesanova and Alexander Veselovsky

ChemistrySelect, 2024, 9
DOI: 10.1002/slct.202401844

Design of Ligand-Operable Protein-Cages That Open Upon Specific Protein Binding

Eric J. Lee, Nika Gladkov, Justin E. Miller and Todd O. Yeates

ACS Synth. Biol., 2024, 13, 157
DOI: 10.1021/acssynbio.3c00383

Cytosolic delivery of monobodies using the bacterial type III secretion system inhibits oncogenic BCR: ABL1 signaling

Chiara Lebon, Sebastian Grossmann, Greg Mann, Florian Lindner, Akiko Koide, Shohei Koide, Andreas Diepold and Oliver Hantschel

Cell Commun Signal, 2024, 22
DOI: 10.1186/s12964-024-01874-6

Preclinical Imaging of Prostate Cancer

Colleen Olkowski, Bruna Fernandes, Gary L. Griffiths, Frank Lin and Peter L. Choyke

Seminars in Nuclear Medicine, 2023, 53, 644
DOI: 10.1053/j.semnuclmed.2023.02.002

Targeting Ras with protein engineering

Atilio Tomazini and Julia M. Shifman

Oncotarget, 2023, 14, 672
DOI: 10.18632/oncotarget.28469

Improving the pharmacokinetics, biodistribution and plasma stability of monobodies

Adrian Valentin Dinh-Fricke and Oliver Hantschel

Front. Pharmacol., 2024, 15
DOI: 10.3389/fphar.2024.1393112

An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo

Johan Nilvebrant, Carlos Fernández Moro, Eleftherios Papalanis, Masih Ostad Novin, Haozhong Ding, Ruonan Li, Maryam Oroujeni, Arun Selvam, Béla Bozóky, Torbjörn Gräslund, Timea Szekerczes, Tatiana Sandalova, Hugh Salter, Adnane Achour, Vladimir Tolmachev, Mikael Björnstedt and Per-Åke Nygren

Translational Oncology, 2025, 61, 102512
DOI: 10.1016/j.tranon.2025.102512

Evolution-guided design of mini-protein for high-contrast in vivo imaging

Nongyu Huang, Yang Cao, Guangjun Xiong, Suwen Chen, Juan Cheng, Yifan Zhou, Chengxin Zhang, Xiaoqiong Wei, Wenling Wu, Yawen Hu, Pei Zhou, Guolin Li, Fulei Zhao, Fanlian Zeng, Xiaoyan Wang, Jiadong Yu, Chengcheng Yue, Xinai Cui, Kaijun Cui, Huawei Cai, Yuquan Wei, Yang Zhang and Jiong Li

Acta Pharmaceutica Sinica B, 2025
DOI: 10.1016/j.apsb.2025.07.015